View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Modality Solutions|24 February 2016

Thermal Package Design and Qualification

The need for a standardized package qualification process was recognized by the International Safe Transit Association (ISTA) in April 2014. Modality Solutions partnered with ISTA and spearheaded this standardization process.

The need for a standardized package qualification process was recognized by the International Safe Transit Association (ISTA) in April 2014. Modality Solutions partnered with ISTA and spearheaded this standardization process.

Thermal Package Design & Qualification

Modality Solutions has the thermal package design and qualification engineering coupled with operational experience to help you maintain product quality and ensuring regulatory compliance.

The US Food and Drug Administration guidance stipulates that temperature-controlled biologics be stored and transported at labelled storage conditions 2°C to 8°C unless stability data is available to support storage at other temperature ranges. Manufacturers also target 2°C to 8°C as guidance for storing temperature-sensitive products.

Since nearly all speciality drugs on the market as of late are temperature and/or shock and vibration sensitive therefore require to be transported in packaging specifically designed to mitigate the risks of excursions or events affecting drug product efficacy.

Ensure Regulatory Compliance, Quality and Safety

Modality Solutions guarantees regulatory compliance for its clients. We not only perform the ASTM D4169 package qualification testing, we also test your drug product interaction with your primary packaging to avoid regulatory approval delays.

Our thermal packaging design and qualification minimizes or eliminates transportation environmental hazards in the supply chain. Modality Solutions enhances the reputation of our clients by ensuring regulatory compliance, drug product quality, and consumer safety during development through clinical trials and into commercial distribution. Our principals have demonstrated subject-matter expertise in International Safe Transit Association (ISTA) standards, cGDP regulations, and Parenteral Drug Association (PDA) guidance documents, along with specialised skills in pharmaceutical packaging, import / export, and controlled-environment logistics management.

Competing priorities, changing expectations, cost pressures, sustainability initiatives, emerging markets - these are some of the challenges facing cold chain management professionals every day. Solutions...
Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell...
Immunomedics (www.immunomedics.com) is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer.
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company headquartered in New York City that specialises in discovering, developing and delivering innovative medicines for patients with...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology